01.27.16
AIDP released the following comments on a double-blind, randomized, placebo-controlled study conducted by researchers at the University of California Los Angeles (UCLA), published in the Frontiers of Physiology, which found that daily doses as low as 1g of PreticX, a XOS (xylooligosaccharide), significantly modified gut microbiota, helping to grow more species of good gut bacteria and reduce bad bacteria in both healthy people, and those who are over-weight with unhealthy blood glucose levels.
According to Jennifer Gu, PhD, AIDP’s vice president of research and development, people who have abnormal glucose levels showed a different gut microbial population as compared to normal people. PreticX significantly modified gut microbiota in both healthy and over-weight subjects, and resulted in dramatic shifts of four bacterial taxa (populations of organisms) associated with people who had abnormal glucose levels.
“It is important for consumers to understand that having good gut flora is an important part of a healthy digestive ecosystem, but one must feed the good gut microbes with prebiotics such as PreticX in order to receive the maximum health benefit,” Dr. Gu added. “Advancing scientific research continues to demonstrate that balanced gut microbiota is essential for digestive function, and that an unhealthy balance in the gut is a precursor to digestive issues and immune dysfunction.”
“This study is an important follow-up to a peer-reviewed and published journal article regarding a 2014 randomized, placebo-controlled trial from UCLA, which demonstrated the mechanism of action, safety and efficacy of a new prebiotic ingredient, PreticX,” Dr. Gu concluded. “The product is a Non-GMO prebiotic that has a GRAS status. It has been shown in clinical studies to significantly increase the proliferation of good gut bacteria, bifidobacterium at a very low dosage as compared to other prebiotics and thus has a significantly better tolerance profile.”
For more information: http://aidp.com/index.php
According to Jennifer Gu, PhD, AIDP’s vice president of research and development, people who have abnormal glucose levels showed a different gut microbial population as compared to normal people. PreticX significantly modified gut microbiota in both healthy and over-weight subjects, and resulted in dramatic shifts of four bacterial taxa (populations of organisms) associated with people who had abnormal glucose levels.
“It is important for consumers to understand that having good gut flora is an important part of a healthy digestive ecosystem, but one must feed the good gut microbes with prebiotics such as PreticX in order to receive the maximum health benefit,” Dr. Gu added. “Advancing scientific research continues to demonstrate that balanced gut microbiota is essential for digestive function, and that an unhealthy balance in the gut is a precursor to digestive issues and immune dysfunction.”
“This study is an important follow-up to a peer-reviewed and published journal article regarding a 2014 randomized, placebo-controlled trial from UCLA, which demonstrated the mechanism of action, safety and efficacy of a new prebiotic ingredient, PreticX,” Dr. Gu concluded. “The product is a Non-GMO prebiotic that has a GRAS status. It has been shown in clinical studies to significantly increase the proliferation of good gut bacteria, bifidobacterium at a very low dosage as compared to other prebiotics and thus has a significantly better tolerance profile.”
For more information: http://aidp.com/index.php
